Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP666852.RAeDEerFP9mkhcMelgjOvJqAJ7Zz5OQQgYAPiSzR9r3XE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP666852.RAeDEerFP9mkhcMelgjOvJqAJ7Zz5OQQgYAPiSzR9r3XE130_assertion type Assertion NP666852.RAeDEerFP9mkhcMelgjOvJqAJ7Zz5OQQgYAPiSzR9r3XE130_head.
- NP666852.RAeDEerFP9mkhcMelgjOvJqAJ7Zz5OQQgYAPiSzR9r3XE130_assertion description "[In patients with endometrial carcinoma who did not receive radiotherapy or chemotherapy before surgery, the presence of decreased levels of pRb2/p130 in tumor cells is associated with a significantly increased risk of recurrence and death of disease, independent of tumor stage and ploidy status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP666852.RAeDEerFP9mkhcMelgjOvJqAJ7Zz5OQQgYAPiSzR9r3XE130_provenance.
- NP666852.RAeDEerFP9mkhcMelgjOvJqAJ7Zz5OQQgYAPiSzR9r3XE130_assertion evidence source_evidence_literature NP666852.RAeDEerFP9mkhcMelgjOvJqAJ7Zz5OQQgYAPiSzR9r3XE130_provenance.
- NP666852.RAeDEerFP9mkhcMelgjOvJqAJ7Zz5OQQgYAPiSzR9r3XE130_assertion SIO_000772 9508194 NP666852.RAeDEerFP9mkhcMelgjOvJqAJ7Zz5OQQgYAPiSzR9r3XE130_provenance.
- NP666852.RAeDEerFP9mkhcMelgjOvJqAJ7Zz5OQQgYAPiSzR9r3XE130_assertion wasDerivedFrom befree-20140225 NP666852.RAeDEerFP9mkhcMelgjOvJqAJ7Zz5OQQgYAPiSzR9r3XE130_provenance.
- NP666852.RAeDEerFP9mkhcMelgjOvJqAJ7Zz5OQQgYAPiSzR9r3XE130_assertion wasGeneratedBy ECO_0000203 NP666852.RAeDEerFP9mkhcMelgjOvJqAJ7Zz5OQQgYAPiSzR9r3XE130_provenance.